This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2015 by Adamis Pharmaceuticals Corporation.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Adamis Pharmaceuticals Corporation
ClinicalTrials.gov Identifier:
NCT01436214
First received: August 31, 2011
Last updated: July 15, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2017
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)